Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures
Background: Second-generation thrombopoietin receptor agonists (TPO-RAs) are emerging as the new standard for managing thrombocytopenia (TCP) in patients with chronic liver diseases (CLDs) undergoing scheduled procedures. However, practical guidance for their routine use in CLD patients undergoing s...
Guardado en:
Autores principales: | Robert Flisiak, Krasimir Antonov, Pavel Drastich, Peter Jarcuska, Marina Maevskaya, Mihály Makara, Željko Puljiz, Borut Štabuc, Anca Trifan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b8263fcddf5497b91835f71ec4c5163 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The pathophysiology of thrombocytopenia in chronic liver disease
por: Mitchell O, et al.
Publicado: (2016) -
Toxic interactions of Romiplostim and Rituximab in normal and thrombocytopenic Rats
por: Saeed H., et al.
Publicado: (2020) -
Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study
por: Hongnan Mo, et al.
Publicado: (2021) -
Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation
por: Longfei Gao, et al.
Publicado: (2021) -
Transfusion-Transmitted Malaria of <i>Plasmodium malariae</i> in Palermo, Sicily
por: Jessica Pulvirenti, et al.
Publicado: (2021)